A Potential Innovative Therapy for Parkinson’s Disease: Selective Destruction of the Pathological Assemblies of Alpha-Synuclein
With the aging of the population, Parkinson’s disease poses a serious socio-economic problem; there is no effective therapy that can arrest/revert the progression of the disease. The hallmarks of Parkinson’s disease and other synucleinopathies are the disordered alpha-synuclein and TPPP/p25. These p...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book Chapter |
| Language: | English |
| Published: |
IntechOpen
2021
|
| Subjects: | |
| Online Access: | https://www.intechopen.com/chapters/74933 |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: A Potential Innovative Therapy for Parkinson’s Disease: Selective Destruction of the Pathological Assemblies of Alpha-Synuclein
- Alpha-Synuclein and the Immune Response in Parkinson’s Disease
- Targeting α-Synuclein-Related Synaptic Pathology: Novel Clues for Parkinson’s Disease Therapy
- Mutations of PARK Genes and Alpha-Synuclein and Parkin Concentrations in Parkinson’s Disease
- Alpha-Synuclein Interactions with Membranes
- Effects of Alpha-Synuclein on Cellular Homeostasis
- Weakly Supervised Segmentation and Classification of Alpha-Synuclein Aggregates in Brightfield Midbrain Images